Bone Marrow versus Peripheral Blood Grafts for Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide
Open Access
- 16 September 2021
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 27 (12) , 1003.e1-1003.e13
Abstract
No abstract availableKeywords
Funding Information
- CareDx
This publication has 32 references indexed in Scilit:
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group ReportTransplantation and Cellular Therapy, 2015
- Unmanipulated Haploidentical Transplants Compared with Other Alternative Donors and Matched Sibling GraftsTransplantation and Cellular Therapy, 2014
- Quality of harvest and role of cell dose in unrelated bone marrow transplantation: An Italian Bone Marrow Donor Registry–Gruppo Italiano Trapianto di Midollo Osseo StudyHematology, 2013
- Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantationBlood, 2009
- Nonresponse Bias in a Survey of Patient Perceptions of Hospital CareMedical Care, 2005
- Relevance of Bone Marrow Cell Dose on Allogeneic Transplantation Outcomes for Patients With Acute Myeloid Leukemia in First Complete Remission: Results of a European SurveyJournal of Clinical Oncology, 2002
- Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapseBlood, 2002
- Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantationBlood, 2002
- Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scaleBone Marrow Transplantation, 1997
- Chronic graft-versus-host syndrome in manThe American Journal of Medicine, 1980